Delaware | 000-06920 | 94-1655526 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3050 Bowers Avenue | ||
P.O. Box 58039 Santa Clara, CA | 95052-8039 | |
(Address of principal executive | (Zip Code) | |
offices) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description | |
99.1 | Press Release issued by Applied Materials, Inc. dated February 13, 2013. |
Applied Materials, Inc. (Registrant) | |||
Date: February 13, 2013 | By: | /s/ Thomas F. Larkins | |
Thomas F. Larkins | |||
Senior Vice President, General Counsel and Corporate Secretary |
Exhibit No. | Description | |
99.1 | Press Release issued by Applied Materials, Inc. dated February 13, 2013. |
• | First quarter non-GAAP EPS of 6 cents at high end of outlook; GAAP EPS of 3 cents |
• | Orders grew 44 percent sequentially led by demand for semiconductor and display equipment |
• | Company expects strong sequential net sales and EPS growth in the second quarter of 2013 |
GAAP Results | Q1 FY2013 | Q4 FY2012 | Q1 FY2012 | |||
Net sales | $1.57 billion | $1.65 billion | $2.19 billion | |||
Operating income (loss) | $39 million | $(499) million | $179 million | |||
Net income (loss) | $34 million | $(515) million | $117 million | |||
Diluted earnings (loss) per share (EPS) | $0.03 | $(0.42) | $0.09 | |||
Non-GAAP Results | ||||||
Non-GAAP operating income | $112 million | $114 million | $344 million | |||
Non-GAAP net income | $69 million | $70 million | $240 million | |||
Non-GAAP diluted EPS | $0.06 | $0.06 | $0.18 |
• | Backlog increased by 31 percent sequentially to $2.11 billion including negative adjustments of $40 million. |
• | Gross margin was 39.8 percent on a non-GAAP basis, up from 38.4 percent in the prior quarter due to a more favorable product mix. GAAP gross margin was 37.0 percent. |
• | Operating expenses were $514 million on a non-GAAP basis, below the company’s expectation due to approximately $20 million in favorable expense items. GAAP operating expenses were $543 million. |
• | The effective tax rate was 24.2 percent on a non-GAAP basis. The GAAP effective tax rate was a benefit of 88.9 percent, reflecting the favorable resolution of a tax audit and the reinstatement of the U.S. R&D tax credit. |
• | The company paid $108 million in cash dividends and used $48 million to repurchase 4 million shares of its common stock. |
• | Cash, cash equivalents and investments ended the quarter at $2.82 billion. |
Three Months Ended | ||||||||||||
(In millions, except per share amounts) | January 27, 2013 | October 28, 2012 | January 29, 2012 | |||||||||
Net sales | $ | 1,573 | $ | 1,646 | $ | 2,189 | ||||||
Cost of products sold | 991 | 1,060 | 1,403 | |||||||||
Gross margin | 582 | 586 | 786 | |||||||||
Operating expenses: | ||||||||||||
Research, development and engineering | 304 | 303 | 304 | |||||||||
Selling, general and administrative | 230 | 237 | 303 | |||||||||
Impairment of goodwill | — | 421 | — | |||||||||
Restructuring charges and asset impairments | 9 | 124 | — | |||||||||
Total operating expenses | 543 | 1,085 | 607 | |||||||||
Income (loss) from operations | 39 | (499 | ) | 179 | ||||||||
Impairment of strategic investments | — | 14 | — | |||||||||
Interest and other expenses | 24 | 24 | 24 | |||||||||
Interest and other income, net | 3 | 5 | 4 | |||||||||
Income (loss) before income taxes | 18 | (532 | ) | 159 | ||||||||
Provision (benefit) for income taxes | (16 | ) | (17 | ) | 42 | |||||||
Net income (loss) | $ | 34 | $ | (515 | ) | $ | 117 | |||||
Earnings (loss) per share: | ||||||||||||
Basic and diluted | $ | 0.03 | $ | (0.42 | ) | $ | 0.09 | |||||
Weighted average number of shares: | ||||||||||||
Basic | 1,198 | 1,220 | 1,299 | |||||||||
Diluted | 1,212 | 1,220 | 1,310 |
(In millions) | January 27, 2013 | October 28, 2012 | ||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,523 | $ | 1,392 | ||||
Short-term investments | 230 | 545 | ||||||
Accounts receivable, net | 1,109 | 1,220 | ||||||
Inventories | 1,278 | 1,272 | ||||||
Other current assets | 625 | 673 | ||||||
Total current assets | 4,765 | 5,102 | ||||||
Long-term investments | 1,062 | 1,055 | ||||||
Property, plant and equipment, net | 900 | 910 | ||||||
Goodwill | 3,518 | 3,518 | ||||||
Purchased technology and other intangible assets, net | 1,302 | 1,355 | ||||||
Deferred income taxes and other assets | 167 | 162 | ||||||
Total assets | $ | 11,714 | $ | 12,102 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 1,287 | $ | 1,510 | ||||
Customer deposits and deferred revenue | 678 | 755 | ||||||
Total current liabilities | 1,965 | 2,265 | ||||||
Long-term debt | 1,946 | 1,946 | ||||||
Other liabilities | 662 | 656 | ||||||
Total liabilities | 4,573 | 4,867 | ||||||
Total stockholders’ equity | 7,141 | 7,235 | ||||||
Total liabilities and stockholders’ equity | $ | 11,714 | $ | 12,102 |
(In millions) | Three Months Ended | ||||||||||
January 27, 2013 | October 28, 2012 | January 29, 2012 | |||||||||
Cash flows from operating activities: | |||||||||||
Net income (loss) | $ | 34 | $ | (515 | ) | $ | 117 | ||||
Adjustments required to reconcile net income (loss) to cash provided by operating activities: | |||||||||||
Depreciation and amortization | 106 | 97 | 112 | ||||||||
Impairment of goodwill | — | 421 | — | ||||||||
Restructuring charges and asset impairments | 9 | 124 | — | ||||||||
Deferred income taxes and other | (78 | ) | 64 | 39 | |||||||
Impairment of strategic investments | — | 14 | — | ||||||||
Share-based compensation | 42 | 44 | 53 | ||||||||
Net change in operating assets and liabilities, net of amounts acquired | (97 | ) | 162 | (140 | ) | ||||||
Cash provided by operating activities | 16 | 411 | 181 | ||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (49 | ) | (41 | ) | (37 | ) | |||||
Cash paid for acquisition, net of cash acquired | — | (1 | ) | (4,179 | ) | ||||||
Proceeds from sales and maturities of investments | 445 | 254 | 313 | ||||||||
Purchases of investments | (143 | ) | (175 | ) | (254 | ) | |||||
Cash provided by (used in) investing activities | 253 | 37 | (4,157 | ) | |||||||
Cash flows from financing activities: | |||||||||||
Proceeds from common stock issuances | 18 | 45 | 2 | ||||||||
Common stock repurchases | (48 | ) | (516 | ) | (200 | ) | |||||
Payments of dividends to stockholders | (108 | ) | (111 | ) | (104 | ) | |||||
Cash used in financing activities | (138 | ) | (582 | ) | (302 | ) | |||||
Effect of exchange rate changes on cash and cash equivalents | — | (3 | ) | (1 | ) | ||||||
Increase (decrease) in cash and cash equivalents | 131 | (137 | ) | (4,279 | ) | ||||||
Cash and cash equivalents — beginning of period | 1,392 | 1,529 | 5,960 | ||||||||
Cash and cash equivalents — end of period | $ | 1,523 | $ | 1,392 | $ | 1,681 | |||||
Supplemental cash flow information: | |||||||||||
Cash payments for income taxes | $ | 32 | $ | 10 | $ | 33 | |||||
Cash refunds from income taxes | $ | 65 | $ | 74 | $ | 3 | |||||
Cash payments for interest | $ | 39 | $ | 7 | $ | 41 |
Q1 FY2013 | Q4 FY2012 | Q1 FY2012 | ||||||||||||||||||||||||||||||||||
(In millions) | New Orders | Net Sales | Operating Income (Loss) | New Orders | Net Sales | Operating Income (Loss) | New Orders | Net Sales | Operating Income (Loss) | |||||||||||||||||||||||||||
SSG | $ | 1,363 | $ | 969 | $ | 134 | $ | 741 | $ | 870 | $ | 41 | $ | 1,418 | $ | 1,344 | $ | 271 | ||||||||||||||||||
AGS | 544 | 471 | 89 | 576 | 621 | 164 | 517 | 534 | 107 | |||||||||||||||||||||||||||
Display | 138 | 87 | 3 | 83 | 93 | 3 | 40 | 104 | 5 | |||||||||||||||||||||||||||
EES | 68 | 46 | (54 | ) | 65 | 62 | (480 | ) | 33 | 207 | (23 | ) | ||||||||||||||||||||||||
Corporate | — | — | (133 | ) | — | — | (227 | ) | — | — | (181 | ) | ||||||||||||||||||||||||
Consolidated | $ | 2,113 | $ | 1,573 | $ | 39 | $ | 1,465 | $ | 1,646 | $ | (499 | ) | $ | 2,008 | $ | 2,189 | $ | 179 |
(In millions) | Q1 FY2013 | Q4 FY2012 | Q1 FY2012 | |||||||||
Restructuring charges and asset impairments, net | $ | 4 | $ | 111 | $ | — | ||||||
Share-based compensation | 42 | 44 | 53 | |||||||||
Other unallocated expenses | 87 | 72 | 128 | |||||||||
Corporate | $ | 133 | $ | 227 | $ | 181 |
Q1 FY2013 | Q4 FY2012 | Q1 FY2012 | ||||||||||||||||
New Orders and Net Sales by Geography | ||||||||||||||||||
(In $ millions) | New Orders | Net Sales | New Orders | Net Sales | New Orders | Net Sales | ||||||||||||
United States | 391 | 401 | 435 | 373 | 467 | 417 | ||||||||||||
% of Total | 19 | % | 25 | % | 30 | % | 23 | % | 23 | % | 19 | % | ||||||
Europe | 134 | 119 | 165 | 271 | 209 | 179 | ||||||||||||
% of Total | 6 | % | 8 | % | 11 | % | 16 | % | 11 | % | 8 | % | ||||||
Japan | 181 | 98 | 184 | 129 | 167 | 217 | ||||||||||||
% of Total | 9 | % | 6 | % | 12 | % | 8 | % | 8 | % | 10 | % | ||||||
Korea | 198 | 205 | 115 | 127 | 666 | 628 | ||||||||||||
% of Total | 9 | % | 13 | % | 8 | % | 8 | % | 33 | % | 29 | % | ||||||
Taiwan | 906 | 565 | 390 | 457 | 367 | 489 | ||||||||||||
% of Total | 43 | % | 36 | % | 27 | % | 28 | % | 18 | % | 22 | % | ||||||
Southeast Asia | 65 | 58 | 74 | 97 | 50 | 79 | ||||||||||||
% of Total | 3 | % | 4 | % | 5 | % | 6 | % | 3 | % | 4 | % | ||||||
China | 238 | 127 | 102 | 192 | 82 | 180 | ||||||||||||
% of Total | 11 | % | 8 | % | 7 | % | 11 | % | 4 | % | 8 | % | ||||||
Employees (In thousands) | ||||||||||||||||||
Regular Full Time | 13.7 | 14.5 | 14.6 |
Three Months Ended | ||||||||||||
(In millions, except percentages) | January 27, 2013 | October 28, 2012 | January 29, 2012 | |||||||||
Non-GAAP Gross Margin | ||||||||||||
Reported gross margin (GAAP basis) | $ | 582 | $ | 586 | $ | 786 | ||||||
Certain items associated with acquisitions1 | 43 | 46 | 104 | |||||||||
Acquisition integration and deal costs | 1 | — | — | |||||||||
Non-GAAP gross margin | $ | 626 | $ | 632 | $ | 890 | ||||||
Non-GAAP gross margin percent (% of net sales) | 39.8 | % | 38.4 | % | 40.7 | % | ||||||
Non-GAAP Operating Income | ||||||||||||
Reported operating income (loss) (GAAP basis) | $ | 39 | $ | (499 | ) | $ | 179 | |||||
Certain items associated with acquisitions1 | 54 | 55 | 115 | |||||||||
Acquisition integration and deal costs | 10 | 13 | 50 | |||||||||
Impairment of goodwill | — | 421 | — | |||||||||
Restructuring charges and asset impairments2, 3 | 9 | 124 | — | |||||||||
Non-GAAP operating income | $ | 112 | $ | 114 | $ | 344 | ||||||
Non-GAAP operating margin percent (% of net sales) | 7.1 | % | 6.9 | % | 15.7 | % | ||||||
Non-GAAP Net Income | ||||||||||||
Reported net income (loss) (GAAP basis) | $ | 34 | $ | (515 | ) | $ | 117 | |||||
Certain items associated with acquisitions1 | 54 | 55 | 115 | |||||||||
Acquisition integration and deal costs | 10 | 13 | 50 | |||||||||
Impairment of goodwill | — | 421 | — | |||||||||
Restructuring charges and asset impairments2, 3 | 9 | 124 | — | |||||||||
Impairment of strategic investments | — | 14 | — | |||||||||
Reinstatement of federal R&D tax credit | (10 | ) | — | — | ||||||||
Resolution of audits of prior years’ income tax filings | (11 | ) | (5 | ) | — | |||||||
Income tax effect of non-GAAP adjustments | (17 | ) | (37 | ) | (42 | ) | ||||||
Non-GAAP net income | $ | 69 | $ | 70 | $ | 240 |
1 | These items are incremental charges attributable to acquisitions, consisting of inventory fair value adjustments on products sold, and amortization of purchased intangible assets. |
2 | Results for the three months ended January 27, 2013 included $4 million of employee-related costs, net, related to the restructuring program announced on October 3, 2012, asset impairment charges of $3 million related to the restructuring program announced on May 10, 2012 and severance charges of $2 million related to the integration of Varian. |
3 | Results for the three months ended October 28, 2012 included severance and other employee-related costs of $106 million related to the restructuring program announced on October 3, 2012, restructuring and asset impairment charges of $12 million related to the restructuring program announced on May 10, 2012, and severance charges of $6 million related to the integration of Varian. |
Three Months Ended | ||||||||||||
(In millions except per share amounts) | January 27, 2013 | October 28, 2012 | January 29, 2012 | |||||||||
Non-GAAP Earnings Per Diluted Share | ||||||||||||
Reported earnings (loss) per diluted share (GAAP basis) | $ | 0.03 | $ | (0.42 | ) | $ | 0.09 | |||||
Certain items associated with acquisitions | 0.03 | 0.04 | 0.07 | |||||||||
Acquisition integration and deal costs | 0.01 | 0.01 | 0.02 | |||||||||
Impairment of goodwill | — | 0.34 | — | |||||||||
Restructuring charges and asset impairments | 0.01 | 0.08 | — | |||||||||
Impairment of strategic investments | — | 0.01 | — | |||||||||
Reinstatement of federal R&D tax credit and resolution of audits of prior years’ income tax filings | (0.02 | ) | — | — | ||||||||
Non-GAAP earnings per diluted share | $ | 0.06 | $ | 0.06 | $ | 0.18 | ||||||
Weighted average number of diluted shares | 1,212 | 1,234 | 1,310 |
Three Months Ended | ||||||||||||
(In millions, except percentages) | January 27, 2013 | October 28, 2012 | January 29, 2012 | |||||||||
Non-GAAP SSG Operating Income | ||||||||||||
Reported operating income (GAAP basis) | $ | 134 | $ | 41 | $ | 271 | ||||||
Certain items associated with acquisitions1 | 44 | 45 | 101 | |||||||||
Acquisition integration and deal costs | 1 | 6 | 14 | |||||||||
Restructuring charges and asset impairments2, 3 | 1 | 3 | — | |||||||||
Non-GAAP operating income | $ | 180 | $ | 95 | $ | 386 | ||||||
Non-GAAP operating margin percent (% of net sales) | 18.6 | % | 10.9 | % | 28.7 | % | ||||||
Non-GAAP AGS Operating Income | ||||||||||||
Reported operating income (GAAP basis) | $ | 89 | $ | 164 | $ | 107 | ||||||
Certain items associated with acquisitions1 | 1 | 3 | 6 | |||||||||
Restructuring charges and asset impairments2, 3 | 1 | 4 | — | |||||||||
Non-GAAP operating income | $ | 91 | $ | 171 | $ | 113 | ||||||
Non-GAAP operating margin percent (% of net sales) | 19.3 | % | 27.5 | % | 21.2 | % | ||||||
Non-GAAP Display Operating Income | ||||||||||||
Reported operating income (GAAP basis) | $ | 3 | $ | 3 | $ | 5 | ||||||
Certain items associated with acquisitions1 | 2 | 1 | 2 | |||||||||
Non-GAAP operating income | $ | 5 | $ | 4 | $ | 7 | ||||||
Non-GAAP operating margin percent (% of net sales) | 5.7 | % | 4.3 | % | 6.7 | % | ||||||
Non-GAAP EES Operating Income | ||||||||||||
Reported operating loss (GAAP basis) | $ | (54 | ) | $ | (480 | ) | $ | (23 | ) | |||
Certain items associated with acquisitions1 | 7 | 7 | 6 | |||||||||
Impairment of goodwill | — | 421 | — | |||||||||
Restructuring charges and asset impairments2, 3 | 3 | 6 | — | |||||||||
Non-GAAP operating loss | $ | (44 | ) | $ | (46 | ) | $ | (17 | ) | |||
Non-GAAP operating margin percent (% of net sales) | (95.7 | )% | (74.2 | )% | (8.2 | )% |
1 | These items are incremental charges attributable to acquisitions, consisting of inventory fair value adjustments on products sold, and amortization of purchased intangible assets. |
2 | Results for the three months ended January 27, 2013 included asset impairment charges of $3 million related to the restructuring program announced on May 10, 2012 and severance charges of $2 million related to the integration of Varian. |
3 | Results for the three months ended October 28, 2012 included restructuring and asset impairment charges of $7 million related to the restructuring program announced on May 10, 2012, and severance charges of $6 million related to the integration of Varian. |
Three Months Ended | |||||||
(In millions) | January 27, 2013 | October 28, 2012 | |||||
Operating expenses (GAAP basis) | $ | 543 | $ | 1,085 | |||
Certain items associated with acquisitions | (11 | ) | (9 | ) | |||
Acquisition integration and deal costs | (9 | ) | (13 | ) | |||
Impairment of goodwill | — | (421 | ) | ||||
Restructuring charges and asset impairments | (9 | ) | (124 | ) | |||
Non-GAAP operating expenses | $ | 514 | $ | 518 |
Three Months Ended | |||
(In millions, except percentages) | January 27, 2013 | ||
Provision (benefit) for income taxes (GAAP basis) (a) | $ | (16 | ) |
Reinstatement of federal R&D tax credit | 10 | ||
Resolutions from audits of prior years' income tax filings | 11 | ||
Income tax effect of non-GAAP adjustments | 17 | ||
Non-GAAP provision for income taxes (b) | $ | 22 | |
Income before income taxes (GAAP basis) (c) | $ | 18 | |
Certain items associated with acquisitions | 54 | ||
Acquisition integration costs | 10 | ||
Restructuring charges and asset impairments | 9 | ||
Non-GAAP income before income taxes (d) | $ | 91 | |
Effective income tax rate (GAAP basis) (a/c) | (88.9 | )% | |
Non-GAAP effective income tax rate (b/d) | 24.2 | % |